Highlights Sernova Corp.

Equities

SVA

CA81732W1041

End-of-day quote Toronto S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
0.3 ^CAD	+3.45%		-6.25%	-57.14%

Apr. 25	Sernova Corp. Announces Board and Management Changes	CI
Apr. 25	Sernova Corp. Announces Workforce Reduction	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sernova Corp. Provides Positive Clinical and Platform Portfolio Update	Apr. 02	CI
Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024	Mar. 18	CI
Sernova Corp. Reports Earnings Results for the Full Year Ended October 31, 2023	Jan. 29	CI
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA	Nov. 27	MT
Sernova Corp. Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System? at the 2023 IPITA-IXA-CTRMS Joint Congress	23-10-30	CI
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System? for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress	23-10-27	CI
Sernova Corp. Announces New Preclinical Data for its Novel Cell Therapy Platform, Cell Pouch System, as Potential Treatment for Post-Operative Hypothyroidism at 2023 American Thyroid Association Annual Meeting	23-09-29	CI
Sernova Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-12	CI
Sernova Corp. Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination with Cell Pouch Device	23-09-07	CI
Sernova Corp. Reports Updated Interim Phase 1/2 Clinical Data for Cell Pouch System at American Diabetes Association Meet	23-06-26	MT
Sernova Corp. Brief: Announcing "Positive" Updated Interim Phase 1/2 Clinical Data for the Cell Pouch System at American Diabetes Association 83rd Scientific Sessions	23-06-26	MT
Sernova Corp. Announces Positive Updated Interim Phase 1/2 Clinical Data for the Cell Pouch Systemâ„¢? at American Diabetes Association 83rd Scientific Sessions	23-06-26	CI
Sernova Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-13	CI
Toronto Stocks Flat After Tuesday's Decline; Loblaw Shares Slide as 1Q Profit Falls, Revenue Misses	23-05-03	DJ
AstraZeneca Teams Up With Sernova to Develop Therapeutic Cell Technologies	23-05-03	MT
Sernova Corp. Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications	23-05-03	CI
Sernova Corp. Announces the Presentation of Preclinical Data	23-04-24	CI
Sernova Corp. Brief: Two Independent Proxy Advisory Firms, Including Glass Lewis & Co. LLC., Recommending Sernova's Shareholders Vote FOR all Management Nominees on Management's White Proxy	23-04-18	MT
Longstanding Shareholders of Sernova Corp. "Concerned" About Company	23-04-17	MT
Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes	23-04-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sernova Corp.

Equities

SVA

CA81732W1041

Highlights

Filters